FGF signaling: its role in bone development and human skeleton diseases

Front Biosci. 2008 Jan 1:13:2842-65. doi: 10.2741/2890.

Abstract

Fibroblast growth factors (FGFs)/Fibroblast growth factor receptors (FGFRs) signaling has recently been found to play very important roles in bone development and diseases. Missense mutations in several FGFs and FGFRs were found in human to cause a variety of congenital bone diseases including chondrodysplasia syndromes, craniosynostosis syndromes, and syndromes with dysregulated phosphate metabolism, etc. In addition to its role in bone development and genetic diseases, FGF signaling is also involved in the maintenance of adult bone homeostasis and fracture healing, etc. Understanding the underlying molecular mechanisms for the role of FGFs/FGFRs in the regulation of bone development and diseases will ultimately lead to better prevention and treatment of FGF signaling-related bone diseases. In this review, we are going to give a summary of the role of FGFs/FGFRs in skeleton development and diseases, and pay more attention to those recent progresses.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Bone Development*
  • Bone Diseases / metabolism*
  • Bone and Bones / metabolism*
  • Craniosynostoses / genetics
  • Fibroblast Growth Factors / metabolism*
  • Fibroblast Growth Factors / physiology*
  • Gene Expression Regulation*
  • Genetic Diseases, Inborn / genetics
  • Genetic Diseases, Inborn / metabolism
  • Humans
  • Mice
  • Mice, Transgenic
  • Models, Biological
  • Osteochondrodysplasias / genetics
  • Receptors, Fibroblast Growth Factor / metabolism*
  • Signal Transduction

Substances

  • Receptors, Fibroblast Growth Factor
  • Fibroblast Growth Factors